{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:50:56Z","timestamp":1792803056278,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guangxi Zhuang Autonomous Region Health Commission Scientific Research Project","award":["Z20201168"],"award-info":[{"award-number":["Z20201168"]}]},{"name":"Guangxi Zhuang Autonomous Region Health Commission Scientific Research Project","award":["Z-A20240546"],"award-info":[{"award-number":["Z-A20240546"]}]},{"name":"Future Academic Star of Guangxi Medical University","award":["WLXSZX25B034"],"award-info":[{"award-number":["WLXSZX25B034"]}]},{"name":"China Undergraduate Innovation and Entrepreneurship Training Program","award":["202510598041"],"award-info":[{"award-number":["202510598041"]}]},{"name":"Guangxi Medical University \u201cFour New\u201d Project","award":["SX202403"],"award-info":[{"award-number":["SX202403"]}]},{"name":"Guangxi Medical University Key Textbook Construction Project","award":["GXMUZDJC2417"],"award-info":[{"award-number":["GXMUZDJC2417"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-27222-3","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:47:42Z","timestamp":1765280862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multi-omics profiling identifies ESM1 as a key mediator of immunoevasion through the SPP1 pathway in bladder cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You-You","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Yan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Su","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Qing","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Qiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"issue":"2","key":"27222_CR1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","volume":"84","author":"I Jubber","year":"2023","unstructured":"Jubber, I. et al. Epidemiology of bladder cancer in 2023: A systematic review of risk factors. Eur. Urol. 84(2), 176\u2013190 (2023).","journal-title":"Eur. Urol."},{"issue":"12","key":"27222_CR2","doi-asserted-by":"publisher","first-page":"9824","DOI":"10.3390\/ijms24129854","volume":"24","author":"I Gilyazova","year":"2023","unstructured":"Gilyazova, I. et al. Epigenetic and immunological features of bladder cancer. Int. J. Mol. Sci. 24(12), 9824 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"27222_CR3","doi-asserted-by":"publisher","first-page":"1235884","DOI":"10.3389\/fimmu.2023.1235884","volume":"14","author":"J van Dorp","year":"2023","unstructured":"van Dorp, J. & van der Heijden, M. S. The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition. Front Immunol. 14, 1235884 (2023).","journal-title":"Front Immunol."},{"issue":"1","key":"27222_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00262-019-02443-4","volume":"69","author":"PL Crispen","year":"2020","unstructured":"Crispen, P. L. & Kusmartsev, S. Mechanisms of immune evasion in bladder cancer. Cancer Immunol. Immunother. 69(1), 3\u201314 (2020).","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"27222_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12885-020-06740-5","volume":"20","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Ou, D. H., Zhuang, D. W., Zheng, Z. F. & Lin, M. E. In silico analysis of the immune microenvironment in bladder cancer. BMC Cancer 20(1), 265 (2020).","journal-title":"BMC Cancer"},{"issue":"21","key":"27222_CR6","doi-asserted-by":"publisher","first-page":"13206","DOI":"10.3390\/ijms232113206","volume":"23","author":"S Harsanyi","year":"2022","unstructured":"Harsanyi, S., Novakova, Z. V., Bevizova, K., Danisovic, L. & Ziaran, S. Biomarkers of bladder cancer: Cell-free DNA, epigenetic modifications and non-coding RNAs. Int. J. Mol. Sci. 23(21), 13206 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"27222_CR7","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"L Dyrskj\u00f8t","year":"2023","unstructured":"Dyrskj\u00f8t, L. et al. Bladder cancer. Nat. Rev. Dis. Primers 9(1), 58 (2023).","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"6","key":"27222_CR8","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.3390\/ijms22062818","volume":"22","author":"L Morales","year":"2021","unstructured":"Morales, L. & Paramio, J. M. Cell therapies in bladder cancer management. Int. J. Mol. Sci. 22(6), 2818 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"27222_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1053\/j.semnuclmed.2020.02.006","volume":"50","author":"C Seidl","year":"2020","unstructured":"Seidl, C. Targets for therapy of bladder cancer. Semin. Nucl. Med. 50(2), 162\u2013170 (2020).","journal-title":"Semin. Nucl. Med."},{"key":"27222_CR10","doi-asserted-by":"publisher","first-page":"687120","DOI":"10.3389\/fonc.2021.687120","volume":"11","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Targeting endothelial cell-specific molecule 1 protein in cancer: A promising therapeutic approach. Front Oncol. 11, 687120 (2021).","journal-title":"Front Oncol."},{"key":"27222_CR11","doi-asserted-by":"publisher","first-page":"705027","DOI":"10.1155\/2013\/705027","volume":"2013","author":"M Delehedde","year":"2013","unstructured":"Delehedde, M., Devenyns, L., Maurage, C. A. & Viv\u00e8s, R. R. Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int. J. Cell Biol. 2013, 705027 (2013).","journal-title":"Int. J. Cell Biol."},{"key":"27222_CR12","doi-asserted-by":"publisher","first-page":"1069528","DOI":"10.3389\/fendo.2022.1069528","volume":"13","author":"Y Xiao","year":"2022","unstructured":"Xiao, Y., Zhang, G., Wang, L. & Liang, M. Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer. Front Endocrinol. (Lausanne) 13, 1069528 (2022).","journal-title":"Front Endocrinol. (Lausanne)"},{"issue":"11","key":"27222_CR13","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.3390\/cancers13112641","volume":"13","author":"A Maiti","year":"2021","unstructured":"Maiti, A. et al. Altered expression of secreted mediator genes that mediate aggressive breast cancer metastasis to distant organs. Cancers (Basel) 13(11), 2641 (2021).","journal-title":"Cancers (Basel)"},{"issue":"17","key":"27222_CR14","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.3390\/cancers14174124","volume":"14","author":"H Jin","year":"2022","unstructured":"Jin, H. & Kim, H. J. P2Y(2)R-mediated PAK1 activation is involved in ESM-1 overexpression in RT-R-MDA-MB-231 through FoxO1 regulation. Cancers (Basel) 14(17), 4124 (2022).","journal-title":"Cancers (Basel)"},{"issue":"4","key":"27222_CR15","doi-asserted-by":"publisher","first-page":"290","DOI":"10.56434\/j.arch.esp.urol.20237604.33","volume":"76","author":"X Liu","year":"2023","unstructured":"Liu, X., Wang, F., Du, W. & Yang, X. ESM-1 mediates cell progression in clear cell renal cell carcinoma by affecting Wnt\/\u03b2-catenin signalling pathway. Arch. Esp. Urol. 76(4), 290\u2013297 (2023).","journal-title":"Arch. Esp. Urol."},{"issue":"1","key":"27222_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12967-023-04819-8","volume":"22","author":"YK Li","year":"2024","unstructured":"Li, Y. K. et al. ANGPTL4 accelerates ovarian serous cystadenocarcinoma carcinogenesis and angiogenesis in the tumor microenvironment by activating the JAK2\/STAT3 pathway and interacting with ESM1. J. Transl. Med. 22(1), 46 (2024).","journal-title":"J. Transl. Med."},{"issue":"1","key":"27222_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12935-020-01717-7","volume":"21","author":"R Feng","year":"2021","unstructured":"Feng, R. et al. Silenced lncRNA SNHG14 restrains the biological behaviors of bladder cancer cells via regulating microRNA-211-3p\/ESM1 axis. Cancer Cell Int. 21(1), 67 (2021).","journal-title":"Cancer Cell Int."},{"issue":"6","key":"27222_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1177\/0004563216629169","volume":"53","author":"E Laloglu","year":"2016","unstructured":"Laloglu, E., Aksoy, H., Aksoy, Y., Ozkaya, F. & Akcay, F. The determination of serum and urinary endocan concentrations in patients with bladder cancer. Ann. Clin. Biochem. 53(6), 647\u2013653 (2016).","journal-title":"Ann. Clin. Biochem."},{"issue":"1","key":"27222_CR19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12935-021-01820-3","volume":"21","author":"B Gao","year":"2021","unstructured":"Gao, B. et al. miR-129-5p inhibits clear cell renal cell carcinoma cell proliferation, migration and invasion by targeting SPN. Cancer Cell Int. 21(1), 263 (2021).","journal-title":"Cancer Cell Int."},{"issue":"9","key":"27222_CR20","first-page":"879","volume":"37","author":"Y Cao","year":"2022","unstructured":"Cao, Y., Huang, F., Liu, J., Qi, H. & Xiao, J. MiR-129-5p\/TRIP13 affects malignant phenotypes of colorectal cancer cells. Histol Histopathol. 37(9), 879\u2013888 (2022).","journal-title":"Histol Histopathol."},{"issue":"5","key":"27222_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.14715\/cmb\/2021.67.5.27","volume":"67","author":"J Hao","year":"2022","unstructured":"Hao, J., Wei, H., Qi, Y. & Liu, H. miR-129\u20135p plays an anticancer role in colon cancer by targeting RSF1. Cell Mol. Biol. (Noisy-le-grand) 67(5), 196\u2013201 (2022).","journal-title":"Cell Mol. Biol. (Noisy-le-grand)"},{"issue":"1","key":"27222_CR22","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12935-022-02582-2","volume":"22","author":"N Huge","year":"2022","unstructured":"Huge, N. et al. MiR-129-5p exerts Wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF. Cancer Cell Int. 22(1), 192 (2022).","journal-title":"Cancer Cell Int."},{"issue":"11","key":"27222_CR23","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13(11), 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"27222_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: Gene set variation analysis for microarray and RNA-seq data. BMC Bioinf. 14, 7 (2013).","journal-title":"BMC Bioinf."},{"issue":"8","key":"27222_CR25","first-page":"2920","volume":"15","author":"L Yang","year":"2023","unstructured":"Yang, L., Dong, Z., Li, S. & Chen, T. ESM1 promotes angiogenesis in colorectal cancer by activating PI3K\/Akt\/mTOR pathway, thus accelerating tumor progression. Aging (Albany NY). 15(8), 2920\u20132936 (2023).","journal-title":"Aging (Albany NY)."},{"issue":"1","key":"27222_CR26","doi-asserted-by":"publisher","first-page":"258","DOI":"10.7150\/ijbs.66839","volume":"19","author":"YK Li","year":"2023","unstructured":"Li, Y. K. et al. Validation of ESM1 related to ovarian cancer and the biological function and prognostic significance. Int. J. Biol. Sci. 19(1), 258\u2013280 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"27222_CR27","doi-asserted-by":"publisher","first-page":"5328192","DOI":"10.1155\/2022\/5328192","volume":"2022","author":"J Li","year":"2022","unstructured":"Li, J. et al. ESM1 is a promising therapeutic target and prognostic indicator for esophageal carcinogenesis\/esophageal squamous cell carcinoma. Biomed. Res. Int. 2022, 5328192 (2022).","journal-title":"Biomed. Res. Int."},{"issue":"6","key":"27222_CR28","doi-asserted-by":"publisher","first-page":"110112","DOI":"10.1016\/j.isci.2024.110112","volume":"27","author":"L Yuan","year":"2024","unstructured":"Yuan, L. et al. Oncogenic HPV-induced high expression of ESM1 predicts poor prognosis and regulates aerobic glycolysis in cervical cancer. iScience 27(6), 110112 (2024).","journal-title":"iScience"},{"key":"27222_CR29","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.omtn.2019.09.023","volume":"18","author":"H Cai","year":"2019","unstructured":"Cai, H. et al. Exosomal MicroRNA-9-3p secreted from BMSCs downregulates ESM1 to suppress the development of bladder cancer. Mol. Ther. Nucleic Acids 18, 787\u2013800 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"27222_CR30","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1016\/j.csbj.2022.05.044","volume":"20","author":"J Segueni","year":"2022","unstructured":"Segueni, J. & Noordermeer, D. CTCF: A misguided jack-of-all-trades in cancer cells. Comput. Struct. Biotechnol. J. 20, 2685\u20132698 (2022).","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"1","key":"27222_CR31","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s13046-024-03255-w","volume":"43","author":"C Liu","year":"2024","unstructured":"Liu, C. et al. SPP1+ macrophages promote head and neck squamous cell carcinoma progression by secreting TNF-\u03b1 and IL-1\u03b2. J. Exp. Clin. Cancer Res. 43(1), 332 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"11","key":"27222_CR32","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41419-024-07241-0","volume":"15","author":"C Liu","year":"2024","unstructured":"Liu, C. et al. NOTCH3 promotes malignant progression of bladder cancer by directly regulating SPP1 and activating PI3K\/AKT pathway. Cell Death Dis. 15(11), 840 (2024).","journal-title":"Cell Death Dis."},{"key":"27222_CR33","doi-asserted-by":"publisher","first-page":"1185208","DOI":"10.3389\/fimmu.2023.1185208","volume":"14","author":"X Liu","year":"2023","unstructured":"Liu, X. et al. ANGPTL2+cancer-associated fibroblasts and SPP1+macrophages are metastasis accelerators of colorectal cancer. Front Immunol. 14, 1185208 (2023).","journal-title":"Front Immunol."},{"issue":"1","key":"27222_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00262-021-02967-8","volume":"71","author":"L Liu","year":"2022","unstructured":"Liu, L. et al. Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma. Cancer Immunol. Immunother. 71(1), 121\u2013136 (2022).","journal-title":"Cancer Immunol. Immunother."},{"key":"27222_CR35","doi-asserted-by":"publisher","first-page":"592854","DOI":"10.3389\/fonc.2021.592854","volume":"11","author":"Y Zheng","year":"2021","unstructured":"Zheng, Y. et al. The correlation between SPP1 and immune escape of EGFR mutant lung adenocarcinoma was explored by bioinformatics analysis. Front Oncol. 11, 592854 (2021).","journal-title":"Front Oncol."},{"issue":"2","key":"27222_CR36","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.yexcr.2017.08.028","volume":"359","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., Du, W., Chen, Z. & Xiang, C. Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma. Exp. Cell Res. 359(2), 449\u2013457 (2017).","journal-title":"Exp. Cell Res."},{"issue":"23","key":"27222_CR37","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.3390\/cancers15235704","volume":"15","author":"T Nedjadi","year":"2023","unstructured":"Nedjadi, T., Ahmed, M. E., Ansari, H. R., Aouabdi, S. & Al-Maghrabi, J. Identification of SPP1 as a prognostic biomarker and immune cells modulator in urothelial bladder cancer: A bioinformatics analysis. Cancers (Basel) 15(23), 5704 (2023).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"27222_CR38","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/biomedicines11010197","volume":"11","author":"C Hao","year":"2023","unstructured":"Hao, C., Lane, J. & Jiang, W. G. Osteopontin and cancer: Insights into its role in drug resistance. Biomedicines 11(1), 197 (2023).","journal-title":"Biomedicines"},{"issue":"1","key":"27222_CR39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12964-023-01306-x","volume":"21","author":"H Ga\u0142ga\u0144ska","year":"2023","unstructured":"Ga\u0142ga\u0144ska, H., Jarmuszkiewicz, W. & Ga\u0142ga\u0144ski, \u0141. Carbon dioxide and MAPK signalling: Towards therapy for inflammation. Cell Commun. Signal. 21(1), 280 (2023).","journal-title":"Cell Commun. Signal."},{"issue":"6","key":"27222_CR40","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41419-023-05882-1","volume":"14","author":"L Yang","year":"2023","unstructured":"Yang, L. et al. Androgen dihydrotestosterone promotes bladder cancer cell proliferation and invasion via EPPK1-mediated MAPK\/JUP signalling. Cell Death Dis. 14(6), 363 (2023).","journal-title":"Cell Death Dis."},{"issue":"2","key":"27222_CR41","doi-asserted-by":"publisher","first-page":"021502","DOI":"10.1063\/5.0195244","volume":"8","author":"S Benmelech","year":"2024","unstructured":"Benmelech, S. et al. Biophysical and biochemical aspects of immune cell-tumor microenvironment interactions. APL Bioeng. 8(2), 021502 (2024).","journal-title":"APL Bioeng."},{"issue":"1","key":"27222_CR42","doi-asserted-by":"publisher","first-page":"10946","DOI":"10.1038\/s41598-025-95731-2","volume":"15","author":"Y Qiu","year":"2025","unstructured":"Qiu, Y. et al. Single-cell sequencing uncovers a high ESM1-expression endothelial cell subpopulation associated with bladder cancer progression and the immunosuppressive microenvironment. Sci. Rep. 15(1), 10946 (2025).","journal-title":"Sci. Rep."},{"issue":"3","key":"27222_CR43","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell 41(3), 374\u2013403 (2023).","journal-title":"Cancer Cell"},{"issue":"12","key":"27222_CR44","doi-asserted-by":"publisher","first-page":"4878","DOI":"10.1182\/blood-2002-07-1956","volume":"101","author":"JE Ohm","year":"2003","unstructured":"Ohm, J. E. et al. VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. Blood 101(12), 4878\u20134886 (2003).","journal-title":"Blood"},{"issue":"3","key":"27222_CR45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3892\/ol.2024.14270","volume":"27","author":"J Zhou","year":"2024","unstructured":"Zhou, J., Zhou, P., Wang, J. & Song, J. Roles of endothelial cell specific molecule-1 in tumor angiogenesis (Review). Oncol. Lett. 27(3), 137 (2024).","journal-title":"Oncol. Lett."},{"key":"27222_CR46","doi-asserted-by":"publisher","first-page":"958368","DOI":"10.3389\/fimmu.2022.958368","volume":"13","author":"Q Song","year":"2022","unstructured":"Song, Q., Zhou, R., Shu, F. & Fu, W. Cuproptosis scoring system to predict the clinical outcome and immune response in bladder cancer. Front Immunol. 13, 958368 (2022).","journal-title":"Front Immunol."},{"issue":"11","key":"27222_CR47","doi-asserted-by":"publisher","first-page":"e22432","DOI":"10.1016\/j.heliyon.2023.e22432","volume":"9","author":"X Xu","year":"2023","unstructured":"Xu, X. et al. Stromal score is a promising index in tumor patients\u2019 outcome determination. Heliyon 9(11), e22432 (2023).","journal-title":"Heliyon"},{"key":"27222_CR48","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"issue":"14","key":"27222_CR49","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.7150\/ijbs.47203","volume":"16","author":"B He","year":"2020","unstructured":"He, B. et al. miRNA-based biomarkers, therapies, and resistance in Cancer. Int J Biol. Sci. 16(14), 2628\u20132647 (2020).","journal-title":"Int J Biol. Sci."},{"issue":"1","key":"27222_CR50","doi-asserted-by":"publisher","first-page":"2290033","DOI":"10.1080\/15384047.2023.2290033","volume":"25","author":"Z Liu","year":"2024","unstructured":"Liu, Z., Du, D. & Zhang, S. Tumor-derived exosomal miR-1247-3p promotes angiogenesis in bladder cancer by targeting FOXO1. Cancer Biol. Ther. 25(1), 2290033 (2024).","journal-title":"Cancer Biol. Ther."},{"issue":"1","key":"27222_CR51","doi-asserted-by":"publisher","first-page":"2315651","DOI":"10.1080\/15384047.2024.2315651","volume":"25","author":"M Xia","year":"2024","unstructured":"Xia, M. et al. miR-10b-5p promotes tumor growth by regulating cell metabolism in liver cancer via targeting SLC38A2. Cancer Biol. Ther. 25(1), 2315651 (2024).","journal-title":"Cancer Biol. Ther."},{"issue":"6","key":"27222_CR52","doi-asserted-by":"publisher","first-page":"460","DOI":"10.3349\/ymj.2020.61.6.460","volume":"61","author":"X Fei","year":"2020","unstructured":"Fei, X., Zhang, P., Pan, Y. & Liu, Y. MicroRNA-98-5p inhibits tumorigenesis of hepatitis B virus-related hepatocellular carcinoma by targeting NF-\u03baB-inducing kinase. Yonsei Med. J. 61(6), 460\u2013470 (2020).","journal-title":"Yonsei Med. J."},{"key":"27222_CR53","doi-asserted-by":"publisher","first-page":"216655","DOI":"10.1016\/j.canlet.2024.216655","volume":"588","author":"P Wu","year":"2024","unstructured":"Wu, P. et al. A unique circulating microRNA pairs signature serves as a superior tool for early diagnosis of pan-cancer. Cancer Lett. 588, 216655 (2024).","journal-title":"Cancer Lett."},{"key":"27222_CR54","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.2147\/CMAR.S284078","volume":"13","author":"Y Yu","year":"2021","unstructured":"Yu, Y. et al. MiR-129-5p suppresses cell proliferation of human osteosarcoma cancer by down-regulating LncRNA Lnc712. Cancer Manag. Res. 13, 2259\u20132264 (2021).","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"27222_CR55","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12935-023-03187-z","volume":"24","author":"Z Wen","year":"2024","unstructured":"Wen, Z. et al. A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma. Cancer Cell Int. 24(1), 18 (2024).","journal-title":"Cancer Cell Int."},{"issue":"1","key":"27222_CR56","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12672-024-00910-8","volume":"15","author":"YL Kong","year":"2024","unstructured":"Kong, Y. L., Wang, H. D., Gao, M., Rong, S. Z. & Li, X. X. LncRNA XIST promotes bladder cancer progression by modulating miR-129-5p\/TNFSF10 axis. Discov. Oncol. 15(1), 65 (2024).","journal-title":"Discov. Oncol."},{"issue":"1","key":"27222_CR57","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1038\/s41598-022-08082-7","volume":"12","author":"S Yerukala Sathipati","year":"2022","unstructured":"Yerukala Sathipati, S. et al. MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma. Sci. Rep. 12(1), 4141 (2022).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27222-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27222-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27222-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T13:03:21Z","timestamp":1765285401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-27222-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["27222"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-27222-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors have reviewed the manuscript and agreed to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Our study was approved by The Ethics Committee of the First Affiliated Hospital of Guangxi Medical University (No. 2024-S371-01). All procedures were conducted within the scope permitted by ethics guidelines and strictly adhered to the ethical principles outlined in the Declaration of Helsinki. All patients provided explicit consent to participate in this study and signed informed consent forms.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}],"article-number":"43439"}}